|

EP0031 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Ellipses Pharma1

Indications

  • Advanced Solid Tumor1
  • NSCLC1
  • Cancer1

Los Angeles, California1 trial

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

David Geffen School of Medicine at UCLA

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.